Sources & References
Peer-reviewed research
Research FAQ
Compound and research-use information
What is CJC-1295 (no DAC) / Ipamorelin Blend?
This research blend combines CJC-1295 without DAC (a GHRH analog) with ipamorelin (a selective ghrelin-receptor agonist). It is supplied as a combined reference preparation for secretagogue-axis research.
What is CJC-1295 (no DAC) / Ipamorelin Blend studied for in the research setting?
The two peptides are studied together in vitro and in preclinical models to investigate complementary GHRH-receptor and GHS-R1a signaling within the growth hormone axis. The blend is used as a research tool for combined-pathway mechanistic studies.
What form is Aurevena's CJC-1295 (no DAC) / Ipamorelin Blend supplied in?
CJC-1295 (no DAC) / Ipamorelin Blend is supplied as a lyophilized (freeze-dried) powder. Every batch is tested by independent, accredited U.S. laboratories for purity and identity, with the Certificate of Analysis published on this product page. Store lyophilized peptide cold and protected from light, and avoid repeated freeze-thaw cycles.
Is CJC-1295 (no DAC) / Ipamorelin Blend intended for human use?
No. CJC-1295 (no DAC) / Ipamorelin Blend is sold by Aurevena strictly for laboratory and research use only. It is not a drug, dietary supplement, cosmetic, or medical device, and is not intended for human or veterinary use, consumption, or for the diagnosis, treatment, cure, or prevention of any disease.





